The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAAA.L Regulatory News (AAA)

  • There is currently no data for AAA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

30 Sep 2020 07:00

RNS Number : 4981A
All Active Asset Capital Limited
30 September 2020
 

30 September 2020

 

All Active Asset Capital Limited

 

('All Active Asset Capital', 'AAA' or 'the Company')

 

Unaudited Interim Results for the six months ended 30 June 2020

 

All Active Asset Capital (AIM: AAA), announces its unaudited interim results for the six months ended 30 June 2020.

Highlights

 

- Completion of equity placings raising gross proceeds of £200,000 and £1,200,000

- Investments of £1,056,000 in equity, warrants and options over warrants in Asimilar Group plc

- Appointment of Rodger Sargent and Simon Grant-Rennick to the board

 

 

Copies of the interim results for the six months to 30 June 2020 are available from the Company's registered address and will be available on the Company's website, www.aaacap.com, later today.

 

For further information:

 

All Active Asset Capital Limited

James Normand, Non-Executive Chairman

Rodger Sargent, Executive Director

www.aaacap.com

 

Allenby Capital Limited (Nominated Adviser and Broker)

Alex Brearley / Nick Athanas

T: +44 (0) 203 328 5656

www.allenbycapital.com 

 

Buchanan (Financial PR)

Richard Oldworth / Chris Lane / Toto Berger

T: +44 (0) 207 466 5000

E: AAAC@buchanan.uk.com 

 

ALL ACTIVE ASSET CAPITAL LIMITED

UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2020

 

CHAIRMAN'S STATEMENT

I am pleased to report the results of All Active Asset Capital Limited ('the Company') together with its subsidiaries ('the Group') for the six months ended 30 June 2020.

Business Review

During the six months ended 30 June 2020, in keeping with its investing policy, the Company made the following investments in relation to Asimilar Group plc ('ASLR'):

The Company has acquired and holds the following interests in ASLR:

- 1,200,000 ASLR shares, the details of which were announced by AAA on 30 March 2020;

- an option to acquire warrants over 15,500,000 ASLR shares, exercisable at 6p per ASLR share each, expiring on 31 October 2020 (with the option expiring on the date on which the warrants expire), the details of which were announced by AAA on 14 May 2020, with certain revised terms being announced on 7 August 2020;

- an option to acquire warrants over 5,000,000 ASLR shares, exercisable at 18p per ASLR share each, expiring on 30 September 2020 (with the option expiring on the date on which the warrants expire), the details of which were announced by AAA on 14 May 2020, with certain revised terms being announced on 7 August 2020;

- an option to acquire warrants over 1,200,000 ASLR shares, exercisable at 5p per ASLR share each, expiring on 31 May 2022, the details of which were announced by AAA on 20 March 2020; and

- warrants over 240,000 ASLR shares, exercisable at 5p per ASLR share each, expiring on 31 May 2022, the details of which were announced by AAA on 20 March 2020.

The investments in equity, warrants and options over warrants in Asimilar have an unaudited carrying value of £1,056,000, being their acquisition price.

The Company also owns 7% of Myanmar Allure Group Co Ltd ('MAG'), a hotel and gaming facility in Myanmar. The Company continues to seek the realisation of its investment in MAG.

Financial Results

During the six months ended 30 June 2020 the Company incurred a net operating loss of £220,463 (2019: net loss of £111,276). The loss was attributable to administrative expenses incurred by the Company.

During the period, there were two equity fund raises, raising a gross £1,400,000. As at 30 June 2020, the Company had deposits and other receivables of £1,219,044 (30 June 2019: £59,032) in the balance sheet and net assets stood at £2,606,077 (30 June 2019: £968,961).

As at 30 June 2020, the Group did not have bank accounts. Cash amounting to £1,219,044 (31 December 2019: £77,737) was held in trust by third party financial institutions and has been classified as deposits and other receivables in the financial statements, as stated in Note 5. Subsequent to 30 June 2020, the Group opened a bank account and almost all of its cash balances are now held in this account.

Board changes

Simon Grant-Rennick joined the board as a non-executive director on 31 January 2020. Rodger Sargent joined as executive director on 28 May 2020, taking over executive duties from myself, as I moved to become non-executive chairman, whilst Robert Berkeley left the board on 16 June 2020.

 

James Normand

Non-executive Chairman

30 September 2020

ALL ACTIVE ASSET CAPITAL LIMITED

CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS

AND OTHER COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED 30 JUNE 2020

 

 

 

 

Six months ended 30 June

 

 

2020

 

2019

 

Notes

£

(Unaudited)

 

£

(Unaudited)

Administrative expenses

 

(220,575)

 

(111,276)

Operating loss before taxation

 

(220,575)

 

(111,276)

Interest income

 

112

 

-

Loss before interest and taxation

 

(220,463)

 

(111,276)

Taxation

 

-

 

-

Loss for the period attributable to the owners of the Company

 

(220,463)

 

(111,276)

Other comprehensive income:

 

 

 

 

Items that may be reclassified subsequently to profit or loss:

 

 

 

 

Exchange profit (loss) on translation of foreign assets

 

33,209

 

(29,251)

Total comprehensive expense for the period

 

(187,254)

 

(140,527)

 

 

 

 

 

Loss per share

 

 

 

 

Basic loss per ordinary share

3(a)

(0.04p)

 

(0.05p)

 

 

 

 

 

 

 

Notes 1 to 6 below form an integral part of these financial statements.

 

 

 

ALL ACTIVE ASSET CAPITAL LIMITED

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 30 JUNE 2020

 

 

 

 

As at

30 June 2020

 

As at

31 Dec 2019

 

Notes

£

(Unaudited)

 

£

(Audited)

ASSETS

 

 

 

 

Non-current assets

 

 

 

 

Investments in equity instruments

4

1,569,710

 

515,199

 

 

1,569,710

 

515,199

Current assets

 

 

 

 

Prepayments

 

35,716

 

20,804

Deposits and other receivables

5

1,219,044

 

117,203

Total current assets

 

1,254,760

 

138,007

Total assets

 

2,824,470

 

653,206

CAPITAL AND RESERVES

 

 

 

 

Share capital

6

8,699,644

 

6,392,944

Reserves

 

(6,093,567)

 

(5,871,615)

Total equity

 

2,606,077

 

521,329

LIABILITIES

 

 

 

 

Current liabilities

 

 

 

 

Other payables and accruals

 

218,393

 

131,877

Total liabilities

 

218,393

 

131,877

Total equity and liabilities

 

2,824,469

 

653,206

Net current assets

 

1,036,377

 

6,130

Total assets less current liabilities

 

2,606,077

 

521,329

Net assets

 

2,606,077

 

521,329

 

 

Approved and authorised for issue by the board of directors on 30 September 2020.

 

 

 

 

 

 

 

 

 

 

 

 

 

James Normand

Chairman

 

 

 

Notes 1 to 6 below form an integral part of these financial statements.

 

 

 

 

ALL ACTIVE ASSET CAPITAL LIMITED

CONDENSED CONSOLIDATED STATEMENT OF CHANGE IN EQUITY

FOR THE SIX MONTHS ENDED 30 JUNE 2020

 

 

 

Share capital

Exchange reserve

Accumulated losses

Total

 

£

£

£

£

 

 

 

 

 

At 1 January 2020

6,392,944

346,646

(6,252,959)

486,631

Total comprehensive expense for the period

-

33,209

(220,463)

(187,254)

Issue of shares in the period

2,306,700

-

-

2,306,700

At 30 June 2020

8,699,644

379,855

(6,473,422)

2,606,077

 

 

 

 

 

At 1 January 2019

6,284,194

374,565

(5,549,271)

1,109,488

Total comprehensive expense for the period

-

(29,251)

(111,276)

(140,527)

At 30 June 2019

6,284,194

345,314

(5,660,547)

968,961

 

 

Notes 1 to 6 below form an integral part of these financial statements.

 

ALL ACTIVE ASSET CAPITAL LIMITED

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

FOR THE SIX MONTHS ENDED 30 JUNE 2020

 

 

 

 

Six months ended 30 June

 

 

2020

 

2019

 

Notes

£

(Unaudited)

 

£

(Unaudited)

Operating activities

 

 

 

 

Loss before interest and taxation

 

(220,575)

 

(111,276)

Adjustments for depreciation of property, plant and equipment:

 

-

 

1,112

Operating loss before working capital changes

 

(220,575)

 

(110,164)

(Increase) in prepayments

 

(14,912)

 

(54,931)

(Increase) in deposits and other receivables

5

(1,101,841)

 

-

Increase in accruals and other payables

 

86,516

 

51,224

Cash used in operations

 

(1,250,812)

 

(113,871)

Interest received

 

112

 

-

Net cash used in operating activities

 

(1,250,812)

 

(113,871)

Financing activities

 

 

 

 

Net proceeds of shares issued for cash

 

1,250,700

 

-

Net (decrease) in cash

 

0

 

(113,871)

Cash at beginning of the period

5

0

 

196,262

Cash at end of the period

5

0

 

82,391

Analysis of balances of cash

 

 

 

 

Cash

5

0

 

82,391

 

 

Notes 1 to 6 below form an integral part of these financial statements.

 

 

ALL ACTIVE ASSET CAPITAL LIMITED

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED 30 JUNE 2020

 

1. GENERAL INFORMATION

 

All Active Asset Capital Limited (the "Company") is an investing company incorporated in the British Virgin Islands on 14 September 2012 with its registered office located on Commerce House, Wickhams Cay 1, P.O. Box 3140, Road Town, Tortola, British Virgin Islands. The ordinary shares of the Company were admitted to trading on the AIM market of the London Stock Exchange on 2 May 2013.

 

The principal activity of the Company is to make investments in accordance with its investing policy.

 

The interim financial information relating to the six months ended 30 June 2020 is unaudited and does not constitute statutory accounts.

 

2. APPLICATION OF NEW AND REVISED INTERNATIONAL FINANCIAL REPORTING STANDARDS ("IFRSs")

 

Statement of compliance

 

These condensed consolidated financial statements have been prepared in accordance with International Accounting Standard ('IAS') 34, Interim financial reporting, issued by the International Accounting Standards Board ("IASB"), and the applicable disclosure provisions of the AIM Rules for Companies issued by the London Stock Exchange. The interim financial information is presented in Great British Pounds ('£').

 

In the current interim period, the Group has applied, for the first time, the following new amendments to IFRSs, which are mandatorily effective for the annual period beginning on or after 1 January 2020 for the preparation of the Group's condensed consolidated financial statements:

 

Amendments to IFRS 3 Definition of a business

Amendments to IFRS 16 Covid-19 related rent concessions

 

The adoption of the amendments to IFRSs in the current period has had no material effect on the Group's financial performance and positions for the current and prior years and/or the disclosures set out in these interim condensed consolidated financial statements.

 

The preparation of condensed consolidated financial statements in conformity with IAS 34 requires management to make judgements, estimates and assumptions that affect the application of policies and reported amounts of assets and liabilities, income and expenses on a year to date basis. Actual results may differ from these estimates.

 

This interim financial information contains condensed consolidated financial statements and explanatory notes. The notes include an explanation of events and transactions that are significant to an understanding of the changes in financial position and performance of the Group since the annual financial statements for the year ended 31 December 2019. The interim condensed consolidated financial statements and notes thereon do not include all of the information required for a full set of financial statements prepared in accordance with International Financial Reporting Standards.

 

3. LOSS PER SHARE

 

(a) Basic loss per share

The calculation of basic loss per share is based on the loss for the period attributable to shareholders of £220,591 (2019: loss of £111,276) divided by the weighted average number of 520,630,987 (2019: 212,826,072) ordinary shares in issue during the period.

 

(b) Diluted loss per share

A diluted loss per share has not been calculated because the difference between that and the basic loss per share is immaterial (since warrants were first issued only 14 days before the end of the period.)

 

 

 

ALL ACTIVE ASSET CAPITAL LIMITED

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED 30 JUNE 2020 (CONTINUED)

 

4. INVESTMENTS IN EQUITY INSTRUMENTS

 

 

30 June

2020

 

31 December

2019

 

£

(Unaudited)

 

£

(Audited)

Unlisted equity securities

 

 

 

Myanmar Allure Group Company Limited

513,710

 

480,501

Investments relating to listed equity securities

 

 

 

Asimilar Group plc ('Asimilar')

1,056,000

 

-

 

 

 

 

 

1,569,710

 

480,501

 

The unlisted equity securities were measured at fair value as at 31 December 2019 and are classified via Level 3 fair value measurement. Fair value is estimated using the Discounted Cash Flow method and is more fully explained in note 13(a) to the 2019 audited financial statements. It is not the Company's practice to undertake a full revaluation exercise at the half year. The directors have no reason to believe that the value of the investment at 30 June 2020 was materially different from that undertaken as at 31 December 2019. The movement in value during the period was entirely the result of currency exchange realignment.

 

The investments in relation to Asimilar take the form of shares, warrants to acquire shares and an option to acquire warrants to acquire shares, made in March and May 2020. The shares of Asimilar are listed on the AIM market of the London Stock Exchange, but as at 30 June 2020 trading in Asimilar's shares was suspended. Accordingly, the investment is reflected in these financial statements at its acquisition price. Asimilar's shares were restored to trading on 25 August 2020.

 

5. DEPOSITS AND OTHER RECEIVABLES

 

At 30 June 2020, the Group did not have bank accounts. Cash amounting to £1,219,044 (31 December 2019: £77,737) was held in trust by third party financial institutions and has been classified as deposits and other receivables.

 

6. SHARE CAPITAL

 

 

 

 

30 June

 

31 December

 

 

 

2020

 

2019

Authorised

 

 

 

 

 

1,000,000,000 ordinary shares of no par value

 

1,000,000,000

 

1,000,000,000

Issued

 

 

 

 

 

774,076,072 (31 December 2019 - 212,826,072)

 ordinary shares of no par value

 

8,699,644

 

6,284,194

 

All of the ordinary shares issued in the period are ranked pari passu in all respects with the existing ordinary shares of the Company.

 

On 16 June 2020, the Company issued 122,000,000 warrants to subscribe for new ordinary shares, exercisable at a price of 2.5 pence per share. All of these were unexercised as at 30 June 2020. The warrants expire on 16 December 2020.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BLGDCSSDDGGC
Date   Source Headline
14th Jul 20208:05 amRNSStatement re Announcement by Asimilar
9th Jul 20201:10 pmRNSBoard Appointment
2nd Jul 20209:20 amRNSBlock admission application
30th Jun 20203:10 pmRNSStatement re Asimilar Interim Results
26th Jun 20201:22 pmRNSExtension of reporting deadline & portfolio update
22nd Jun 20204:35 pmRNSPrice Monitoring Extension
19th Jun 20202:41 pmRNSHolding(s) in Company
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn
18th Jun 20204:35 pmRNSPrice Monitoring Extension
17th Jun 202012:46 pmRNSHolding(s) in Company
16th Jun 20204:41 pmRNSSecond Price Monitoring Extn
16th Jun 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20209:30 amRNSAdmission of Placing Shares and Board Change
12th Jun 202011:30 amRNSResult of Extraordinary General Meeting
28th May 20207:00 amRNSBoard changes
22nd May 20208:41 amRNSNotice of Extraordinary General Meeting
14th May 20204:40 pmRNSSecond Price Monitoring Extn
14th May 20204:35 pmRNSPrice Monitoring Extension
14th May 20204:22 pmRNSRevised placing to raise £1.2 million
14th May 20202:06 pmRNSSecond Price Monitoring Extn
14th May 20202:01 pmRNSPrice Monitoring Extension
14th May 202012:19 pmRNSOptions over warrants in Asimilar Group plc
7th May 20205:42 pmRNSFurther re. proposed conditional placing
28th Apr 20207:00 amRNSUpdate on proposed placing to raise £1.26 million
17th Apr 20202:57 pmRNSHolding(s) in Company
17th Apr 20202:52 pmRNSHolding(s) in Company
17th Apr 20202:50 pmRNSHolding(s) in Company
16th Apr 202011:53 amRNSHolding(s) in Company
14th Apr 20207:00 amRNSHolding(s) in Company
3rd Apr 20203:24 pmRNSProposed conditional placing
30th Mar 202012:10 pmRNSInvestment in shares in Asimilar Group Plc
26th Mar 20201:25 pmRNSHolding(s) in Company
20th Mar 20202:15 pmRNSInvestment in warrants in Asimilar Group Plc
10th Mar 202012:54 pmRNSChange of Board Roles
28th Feb 20205:00 pmRNSTotal Voting Rights
27th Feb 202012:58 pmRNSHolding(s) in Company
27th Feb 202012:58 pmRNSHolding(s) in Company
27th Feb 202011:13 amRNSHolding(s) in Company
24th Feb 202012:24 pmRNSResult of Extraordinary General Meeting
10th Feb 202011:01 amRNSAvailability of circular
5th Feb 20203:49 pmRNSProposed conditional placing to raise £200,000
31st Jan 202012:17 pmRNSBoard changes
15th Oct 20192:10 pmRNSChange of Name
10th Oct 201911:09 amRNSResult of Extraordinary General Meeting
30th Sep 20195:00 pmRNSTotal Voting Rights
24th Sep 20191:51 pmRNSInterim Results for the period ended 30 June 2019
23rd Sep 20191:00 pmRNSCompletion of placing and other matters
20th Sep 201911:04 amRNSAvailability of circular
17th Sep 201911:19 amRNSPlacing to raise £125,000 and other matters
30th Jul 20191:39 pmRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.